
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-09-07-2016
- Volume 11
- Issue 9
Eppendorf Expands Single-Use Vessel Portfolio
The company announced that it will be expanding its portfolio of single-use vessels for fermentation.
On July 5, 2016, Eppendorf announced that it would be expanding its portfolio of rigid-wall single-use vessels for fermentation. According to the company, the Eppendorf BioBLU 3f was developed specifically for microbial bioprocessing in working volumes of 1.25 to 3.75 L, extending the full range of operation for single-use fermentation from 60 mL to 3.75 L.
Eppendorf BioBLU f Single-Use Vessels specifically address the demands of high cell density fermentation of bacteria, yeasts, and fungi. Magnetic overhead drives featuring impellers support agitation rates up to 1200 rpm and provide high-performance mass transfer. The integrated cooling baffles enable efficient heat removal for exothermic processes and the rigid-wall industrial stirred-tank design ensures scalability and simplifies technology transfer.
Source: Eppendorf
Articles in this issue
about 9 years ago
Putting Shelf-Life to the Testabout 9 years ago
The Enzymatic Catalysis Route to Going Greenabout 9 years ago
CMOs Step Up to Test New Bioprocessing Technologyabout 9 years ago
SGS Opens New Facility in Wiesbaden, Germanyabout 9 years ago
CSafe Acquires Kalliboxabout 9 years ago
CordenPharma in France Reports Successful FDA Inspectionabout 9 years ago
Automated Infrared Microscope Effectively Analyzes Micro Samplesabout 9 years ago
Copley Scientific Launches Products for Tablet Dissolution Testingabout 9 years ago
PANalytical launches the Empyrean Nano editionabout 9 years ago
Fuji Health Changes Name to Fuji Chemical Industries USA, Inc.Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





